Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Roche patents non-nucleoside reverse transcriptase inhibitors

Nov. 16, 2004

Update on the effects and safety of a tenofovir/emtricitabine combination in HIV-infected patients

Nov. 15, 2004

Non-nucleoside reverse transcriptase inhibitors described by Roche Bioscience

Nov. 15, 2004

Canadian HIV Trials Network lends support to phase I/II study of IR-103

Nov. 15, 2004

Phase II study investigates Racivir for HIV

Nov. 15, 2004

Potent inhibition of HIV entry by CCR5 mAb

Nov. 10, 2004

Panacos amends merger agreement with V.I. Technologies

Nov. 10, 2004

Phase II data support 873140 as an antiviral for HIV infection

Nov. 9, 2004

Add-on therapy with Reverset reduces viral load in HIV-infected patients

Nov. 9, 2004

Shionogi scientists present new HIV integrase inhibitors

Nov. 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...